Martin Glen brings an unusual combination of 15 years as a global hedge fund manager focused on IPOs and previous experience as a chemicals analyst to his role investing in UK university spinouts at Parkwalk Advisors, applying a fundamentals-driven approach that contrasts with typical VC hype culture. His career path from London chemical company analysis to Hong Kong industrial coverage and back to London IPO-focused hedge fund management before joining Parkwalk gives him a rare mix of Asian industrial, public markets, and deep-tech venture perspectives that he applies to a highly specific mandate of backing IP-rich university science spinouts.